NSAID-ASSOCIATED GASTRIC ULCER : ADULT OVER 18 YEARS, 20 MG ONCE DAILY FOR 4 - 8 WEEKS; PROPHYLAXIS IN PATIENTS WITH AN INCREASED RISK OF GASTRODUODENAL COMPLICATIONS WHO REQUIRE CONTINUED NSAID TREATMENT, 20 MG DAILY
GASTRO-OESOPHAGEAL REFLUX DISEASE: ADULT AND CHILD OVER 12 YEARS, 40 MG ONCE DAILY FOR 4 WEEKS, CONTINUED FOR FURTHER 4 WEEKS IF NOT FULLY HEALED OR SYMPTOMS PERSIST; MAINTENANCE 20 MG DAILY
SYMPTOMATIC TREATMENT IN THE ABSENCE OF OESOPHAGITIS, 20 MG DAILY FOR UP TO 4 WEEKS, THEN IN ADULTS OVER 18 YEARS 20 MG DAILY WHEN REQUIRED
ZOLLINGER-ELLISON SYNDROME: ADULT OVER 18 YEARS, INITIALLY 40 MG TWICE DAILY, ADJUSTED ACCORDING TO RESPONSE; USUAL RANGE 80 - 160 MG DAILY (ABOVE 80 MG IN 2 DIVIDED DOSES)
COUNSELLING DO NOT CHEW OR CRUSH TABLETS, SWALLOW WHOLE OR DISPERSE IN WATER
BY INTRAVENOUS INJECTION OVER AT LEAST 3 MINUTES OR BY INTRAVENOUS INFUSION, ADULT OVER 18 YEARS, GASTRO-OESOPHAGEAL REFLUX DISEASE, 40 MG ONCE DAILY; SYMPTOMATIC REFLUX DISEASE WITHOUT OESOPHAGITIS, TREATMENT OF NSAID-ASSOCIATED GASTRIC ULCER, PREVENTION OF NSAID-ASSOCIATED GASTRIC OR DUODENAL ULCER, 20 MG DAILY; CONTINUE UNTIL ORAL ADMINISTRATION POSSIBLE.